Pasithea Therapeutics Corp.
KTTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4,123 | $7,217 | $5,341 | $6,923 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,406 | $1,420 | $784 | $446 |
| Total Curr. Assets | $5,529 | $8,637 | $6,125 | $7,368 |
| Property Plant & Equip (Net) | $0 | $114 | $118 | $122 |
| Goodwill | $1,263 | $1,263 | $1,263 | $1,263 |
| Intangibles | $6,839 | $6,996 | $7,154 | $7,311 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$0 | $0 | $0 | $0 |
| Total NC Assets | $8,101 | $8,373 | $8,534 | $8,696 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $13,631 | $17,009 | $14,659 | $16,065 |
| Liabilities | – | – | – | – |
| Payables | $1,338 | $1,582 | $0 | $1,120 |
| Short-Term Debt | $0 | $155 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $39 | $0 | $1,595 | $0 |
| Total Curr. Liab. | $1,377 | $1,737 | $1,595 | $1,120 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $47 | $94 | $85 | $162 |
| Total NC Liab. | $47 | $94 | $85 | $162 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,424 | $1,831 | $1,680 | $1,282 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $0 | $0 |
| Retained Earnings | -$59,900 | -$56,862 | -$53,146 | -$49,583 |
| AOCI | $18 | $6 | $0 | -$7 |
| Other Equity | $72,087 | $72,034 | $66,125 | $64,372 |
| Total Equity | $12,207 | $15,178 | $12,979 | $14,783 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $13,631 | $17,009 | $14,659 | $16,065 |
| Net Debt | -$4,123 | -$7,062 | -$5,341 | -$6,923 |